![Sean Cassidy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sean Cassidy
Directeur/Bestuurslid bij
HOOA PHARPAR
Vermogen: - $ op 31-05-2026
Profiel
Momenteel is Sean A. Cassidy Chief Financial Officer voor Arvinas, Inc., Chief Financial Officer van Arvinas Operations, Inc. (een dochteronderneming van Arvinas, Inc.) en penningmeester bij The Friends of Yale New Haven Children's Hospital. In het verleden bekleedde de heer Cassidy de functie van Chief Financial Officer & VP-Administration bij Renetx Bio, Inc., Chief Financial Officer & Vice President voor CuraGen Corp., Director & Controller bij Deloitte & Touche LLP en Director & Controller bij 454 Life Sciences Corp. Hij behaalde een MBA en een bachelorgraad aan de Universiteit van Connecticut.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
HOOKIPA PHARMA INC. -.--% | 04-06-2025 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Sean Cassidy
| Bedrijven | Functie | Begin |
|---|---|---|
| HOOA PHARPAR | Directeur/Bestuurslid | 22-07-2024 |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Financieel Directeur/CFO | - |
The Friends of Yale New Haven Children's Hospital | Treasurer | - |
Abbratech, Inc.
 Abbratech, Inc. BiotechnologyHealth Technology Develops antibodies | Directeur/Bestuurslid | - |
Renetx Bio, Inc.
 Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Directeur/Bestuurslid | - |
Eerdere bekende functies van Sean Cassidy
| Bedrijven | Functie | Einde |
|---|---|---|
| ARVINAS, INC. | Financieel Directeur/CFO | 29-02-2024 |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Financieel Directeur/CFO | 01-06-2013 |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Financieel Directeur/CFO | 01-10-2009 |
454 Life Sciences Corp.
 454 Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides medical testing services to determine the nucleotide sequence of whole genomes | Directeur/Bestuurslid | 01-12-2008 |
| ░░░░░░░░ ░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Sean Cassidy
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
99
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Health Technology |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
454 Life Sciences Corp.
454 Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides medical testing services to determine the nucleotide sequence of whole genomes | Health Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
The Friends of Yale New Haven Children's Hospital | |
HOOKIPA Pharma, Inc.
 HOOKIPA Pharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers | Health Technology |
Abbratech, Inc.
Abbratech, Inc. BiotechnologyHealth Technology Develops antibodies | Health Technology |
